Cargando…
Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome
We performed a multi-centre randomized controlled trial to compare the efficacy of mycophenolate mofetil (MMF) to that of cyclosporine A (CsA) in treating children with frequently relapsing nephrotic syndrome and biopsy-proven minimal change disease. Of the 31 randomized initially selected patients,...
Autores principales: | Dorresteijn, Eiske M., Kist-van Holthe, Joana E., Levtchenko, Elena N., Nauta, Jeroen, Hop, Wim C. J., van der Heijden, Albert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462920/ https://www.ncbi.nlm.nih.gov/pubmed/18622632 http://dx.doi.org/10.1007/s00467-008-0899-6 |
Ejemplares similares
-
Efficacy of Mycophenolate Mofetil as a Remission Maintaining Agent in Idiopathic Childhood Nephrotic Syndrome
por: Nandi, M., et al.
Publicado: (2019) -
The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
por: Pyo, Jung Yoon, et al.
Publicado: (2021) -
Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
por: Mao, Youying, et al.
Publicado: (2018) -
Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome
por: Farruggia, Piero, et al.
Publicado: (2011) -
Mycophenolate mofetil in children with steroid-dependent and/or frequently relapsing nephrotic syndrome
por: Al-Akash, Samhar, et al.
Publicado: (2005)